Public Hearings

Past Public Hearings and Transcripts

DateLocationTranscriptProgramSubmissions
30 Aug 2018Brisbane, QLD(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (30/08/2018) 28462PDF Format
31 Aug 2018Townsville, QLD(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (31/08/2018) 28463PDF Format
11 Oct 2018Canberra, ACT(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (11/10/2018) 28562PDF Format
15 Oct 2018Canberra, ACT(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (15/10/2018) 28576PDF Format
05 Nov 2018Melbourne, VIC(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (5/11/2018) 28608PDF Format
08 Nov 2018Canberra, ACT(HTML & PDF)PDF: Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force (8/11/2018) 28618PDF Format
  1. Supplementary submission 71.2 from Mr Mark Reid – response to evidence given by Mr Brian McCarthy during the public hearing in Brisbane on 30 August 2018 (PDF 3062 KB)
  2. Submission 112 from Dr Ian Gardner – response to evidence given by Mr Stuart McCarthy during the public hearing in Brisbane on 30 August 2018 (PDF 65 KB)


About this inquiry

Inquiry into the use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.



Inquiry Status

Report Tabled

Accessibility

If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility